Home / Health / Milestone Cancer Treatment: Two Tumors, Five Sessions
Milestone Cancer Treatment: Two Tumors, Five Sessions
10 Aug
Summary
- 78-year-old patient received successful non-invasive cancer treatment.
- MR-Guided Adaptive Stereotactic Body Radiotherapy used for treatment.
- Patient completed treatment with no side effects or interruptions.

A 78-year-old man with advanced lung cancer that had metastasized to an adrenal gland has been successfully treated using a groundbreaking non-invasive method. The patient presented with breathlessness, and imaging confirmed two tumors: one in the left lung and another in the left adrenal gland. Biopsy confirmed adenocarcinoma of lung origin.
The case was classified as oligometastatic disease, making cure-directed treatment a viable option. Doctors opted for MR-Guided Adaptive Stereotactic Body Radiotherapy, a non-surgical technique delivering concentrated radiation over several sessions. This posed a significant challenge due to the tumors' locations near critical organs and the lung tumor's movement with respiration.
The medical team leveraged the MR-Linac's capabilities, performing daily MRIs to adapt the treatment plan in real-time. This ensured precise radiation delivery to both tumors while safeguarding surrounding healthy tissues. The patient received 40 Gy to the lung tumor and 60 Gy to the adrenal tumor across five sessions.
Remarkably, the patient completed the entire treatment course without any interruptions or side effects. He remained stable and was discharged in satisfactory condition. This achievement represents a significant advancement, particularly for elderly patients or those unsuitable for surgery, offering a non-invasive path to treat primary cancer and its spread.